Funding

Gene, Cell, & RNA Therapy Landscape: Q1 2021

David M. Barrett, J.D., M.S. | April 15, 2021

The first of a new, quarterly publication from ASGCT, the Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

ASGCT News  |  Funding

Read Full Story

ASGCT Selects First-Ever Career Development Grant Group, Awards Total $245,000

ASGCT Staff | January 07, 2019

The American Society of Gene and Cell Therapy’s (ASGCT) first class of 14 career development grant recipients were named by a selection committee made up of industry leaders identified by the ASGCT board of directors. In total, the Society will distribute $245,000.

ASGCT News  |  Funding

Read Full Story

ASGCT Offers Up To $245,000 in Career Development Grants

ASGCT's New Investigator and Trainee Committees | June 11, 2018

In support of trainees and members developing their careers, the American Society of Gene & Cell Therapy will distribute up to 14 grants worth a total of $245,000 in 2018. Applications are accepted through August 1.

ASGCT News  |  Funding

Read Full Story

Regenerative Medicine Gets Boost in Fiscal Year 2018 Omnibus Appropriations Package

ASGCT Staff | March 26, 2018

After five stopgap continuing resolutions since the fiscal year began October 1, and two brief partial government shutdowns, President Trump on Friday signed into law the Omnibus Appropriations Package which included an 8.8 percent year-over-year budget increase for the NIH.

Funding  |  Policy Updates

Read Full Story

FDA Announces Pilot for Orphan Designation Requests

ASGCT Staff | March 07, 2018

FDA Commissioner Scott Gottlieb, M.D. announced last week new actions the FDA is taking to support and expedite development of rare disease products, including a new pilot for more efficient orphan designation requests.

Funding  |  Policy Updates

Read Full Story

Credit: Office of Intramural Training & Education, National Institutes of Health

Biomedical Researchers Get Mixed News in U.S. President’s 2019 Budget Request

ASGCT Staff | February 19, 2018

While the FDA receives a commendable $473 million budget increase, the NIH and various associated research organizations are expecting a budget freeze. ASGCT will continue to encourage congressional support for robust funding increases for both the FDA and NIH.

ASGCT News  |  Funding

Read Full Story

James H. Shannon Building (Building One). Credit: Lydia Polimeni, National Institutes of Health. License: CC BY-NC 2.0

Budget Deal Allows Funding Increase for NIH

ASGCT Staff | February 09, 2018

Following a brief shutdown overnight, new budget legislation signed into law assumes an increase in funding for the NIH of $2 billion over the next two years.

Funding

Read Full Story

Impact of the Tax Plan on Gene and Cell Therapy

ASGCT Staff | December 22, 2017

Both chambers of the United States Congress ushered through a bill to drastically transform American tax policy. That reconciled bill was signed by the president with a couple of added provisions that both maintain conditions for graduate researchers and maintains half of the Orphan Drug Tax Credit, a research incentive used to develop groundbreaking treatments for rare diseases.

Funding  |  Policy Updates

Read Full Story

The Congressional Tax Plan is a Half-Measure Improvement for Medical Researchers

ASGCT Staff | December 21, 2017

Though maintaining tuition waivers for graduate students is a net positive, cutting the Orphan Drug Tax Credit in half will harm medical research in the United States. ASGCT is disappointed that Congress missed this opportunity to improve conditions for medical innovation in the United States.

Funding  |  Policy Updates

Read Full Story

Credit: Gage Skidmore (flickr.com)/Creative Commons 2.0

To Senator Hatch: Save the ODTC

Dr. Helen E. Heslop & Dr. Rachel Salzman | December 12, 2017

The retention of the Orphan Drug Tax Credit within the final tax bill is crucially important in providing the incentives necessary for the innovation of gene therapies for rare diseases.

ASGCT News  |  Funding  |  Policy Updates  |  President's Message

Read Full Story

Why the House Tax Plan on Tuition Waivers is Bad for Science and for America

ASGCT Trainee Committee | December 01, 2017

Taxing tuition waivers will have a deleterious impact on graduate students, science, and society.

Funding

Read Full Story

Credit: Architect of the Capitol/Public Domain

ASGCT Joins With More Than 200 Groups in Support of Orphan Drug Tax Credit

ASGCT Staff | November 08, 2017

As part of proposed tax reform, the Trump administration and the United States House of Representatives has proposed eliminating the Orphan Drug Tax Credit (ODTC). Contact your Senators and Representatives today to help keep this important research incentive.

ASGCT News  |  Funding

Read Full Story